Abstract: Methods and apparatus for producing an image of an object with a multi-slice imaging apparatus having a row of detectors are provided. The method includes generating a first partial image using projection data acquired at a first imaging position in a step-and-shoot imaging mode, generating a second partial image using projection data acquired at a second imaging position, and combining the partial images to form a final image.

Abstract: A fluid container includes a body having a depth extending between a base interior surface and an opening of the fluid container. The fluid container also includes a capillary material compression structure having an extension depth extending from the opening to a capillary material where the capillary material compression structure is in contact with the capillary material, and the ratio of the extension depth to the depth is 0.35 or greater.

Abstract: Method and apparatus for locally enhancing image data represented as pixels having CT numbers is provided. The image data includes bony structures, and the method comprises segmenting pixels within the image data into areas based on the pixel's CT number. A first area represents a combination of soft tissue and lower density bones and a second area represents higher density bones. A subset of pixels is identified within the first area representative of the lower density bones. An enhancement is applied to the subset of pixels within the first area and to the second area to create an enhanced dataset, and a locally enhanced image is generated based on the image data and the enhanced dataset.

Abstract: Drug depot delivery devices and methods are provided for delivering one or more drug depots to one or more sites beneath the skin of a patient with or without repositioning the cannula. The device has a cannula capable of insertion to the site beneath the skin of the patient and one or more side port openings for delivering a drug depot. The side port openings are spaced a distance from the blunt tip, which will allow the user to implant at a set distance from a nerve. The device may also include an electronic monitor for detecting the proximity of the tip of the cannula to a nerve. In some embodiments, a method of delivering a drug depot is provided by detecting the nerve and delivering the drug depot at or near the nerve.

Abstract: A system for detection of linear underground anomalies passing under surface roads comprises an electromagnetic (EM) gradiometer mounted on a vehicle trailer. A transmitter is mounted to the front bumper of a car or vehicle towing the trailer and provides carrier synchronization information to the EM-gradiometer. An opportunistic radio station can be used as an illuminator. The transmitter or ground wave from an opportunistic radio station directs radio waves down into the ground where objects like linear underground anomalies and their equipment will produce reflections and scattered waves. These reflections will have phase angles and magnitudes that can be interpreted for characterizing information about the linear underground anomalies. Each EM-gradiometer measurement is tagged with GPS location information and then stored in a database. Subsequent passes over the same roadways and tracks are compared (change detection) to the earlier stored data.

Abstract: Methods and compositions for treating a tissue within a synovial joint in a patient in need of such treatment are provided. The methods and compositions involve inserting a drug depot through the synovial joint and attaching the drug depot to the inside of the synovial joint capsule so that the drug depot does not substantially interfere with movement of the joint, wherein said depot comprises a polymer and at least one pharmaceutical agent.

Abstract: Effective treatments of pain and/or inflammation from tendonitis, carpal tunnel syndrome, tarsal tunnel syndrome, osteoarthritis, bursitis and/or an oral-facial disease are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation from tendonitis, carpal tunnel syndrome, tarsal tunnel syndrome, osteoarthritis, bursitis and/or an oral-facial disease.

Abstract: Effective treatments of pain and/or inflammation are provided. Through the administration of an effective amount of at least one beta adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation.

Abstract: Effective methods for treating pain are provided. Through the injection of liquid formulation comprising an active ingredient followed by the administration of drug depot comprising an active ingredient at or near a target site, one can effectively treat pain. This methodology is particularly effective to treat acute radicular pain.

Abstract: Effective treatments of pain and/or inflammation are provided. Through the administration of an effective amount of at least one alpha adrenergic agonist at or near a target site, one can reduce, prevent or treat pain and/or inflammation.

Abstract: Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.

Abstract: Effective treatments of pain and inflammation are provided. Through the administration of an effective amount of fluocinolone at or near a target site, one can reduce, prevent or treat inflammation and pain and autoimmune disorders. In various embodiments, fluocinolone formulations may be provided within biodegradable polymers to reduce, prevent or treat sciatic pain and/or inflammation. In various embodiments, prevent transplant rejection for at least twenty-five days. In some embodiments, the pain relief can be for at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.

Abstract: Scanning fiber devices are disclosed. In one aspect, a scanning fiber device may include an actuator tube. The scanning fiber device may also include a cantilevered free end portion of an optical fiber. The cantilevered free end portion of the optical fiber may have an attached end that is coupled with the actuator tube. The cantilevered free end portion of the optical fiber may also have a free end to be moved by the actuator tube. At least a portion of a length of the cantilevered free end portion of the optical fiber may be disposed within the actuator tube. Methods of using scanning fiber devices are also disclosed.

Abstract: A system (and methods) for transferring multimedia information from a source location to a destination location through one or more networks, which may be different. The system has a source output which provides a first stream of information in a first format. The system also has a destination input which receives a second stream of information in a second format. A proxy transcoder server (“PTS”) is coupled between the source output and the destination input. The PTS has a transcoding module transcoding data. The PTS also has a capability module identifying a first capability of the source output and a second capability of the destination input, and selecting a transcoding process based upon the first capability and the second capability.

Abstract: A CT system includes a rotatable gantry having an opening for receiving a subject to be scanned, a rotatable gantry having an opening for receiving a subject to be scanned, an x-ray source configured to project x-rays having multiple energies toward the subject, and a generator configured to energize the x-ray source to a first voltage and configured to energize the x-ray source to a second voltage, the first voltage distinct from the second voltage. The system further includes a controller configured to cause the generator to energize the x-ray source to the first voltage for a first duration, acquire imaging data for at least one view during at least the first duration, after the first duration, cause the generator to energize the x-ray source to the second voltage for a second duration, and acquire imaging data for two or more views during at least the second duration.

Abstract: Films containing microlayer structures are provided. In a general embodiment, the present disclosure provides an autoclavable film containing a first microlayer of a heat resistant polymer and a second microlayer of a flexible polymer attached to the first microlayer. Each of the first microlayer and the second microlayer has a thickness ranging between about 0.01 microns and about 10 microns.

Abstract: A fluid container, including a body having a base surface, a capillary fluid volume disposed over the base surface, and an outlet compartment having at least one outlet wall disposed within the body and extending from the base surface into the capillary fluid volume. The body also includes at least two fluidically segregated free fluid compartments, where each compartment includes at least one sidewall disposed within the body. The at least one sidewall includes a compression edge wherein at least a portion of the compression edge is flush with the at least one outlet wall edge.

Abstract: This invention provides for using a locally delivered low dose of a corticosteroid to treat pain caused by any inflammatory disease including sciatica, herniated disc, stenosis, mylopathy, low back pain, facet pain, osteoarthritis, rheumatoid arthritis, osteolysis, tendonitis, carpal tunnel syndrome, or tarsal tunnel syndrome. More specifically, a locally delivered low dose of a corticosteroid can be released into the epidural space, perineural space, or the foramenal space at or near the site of a patient's pain by a drug pump or a biodegradable drug depot.

Abstract: A fluid cartridge for a printing device includes a housing having a base and a first and second chamber. A wall extends outwardly from and substantially normal to the base and is configured to separate the housing, thereby forming the first and second chambers. An air/ink exchange port is defined in a bottom portion of the wall and adjacent to the base. A longitudinal air flow-restricting member is disposed adjacent the air/ink exchange port and on the base, and extends outwardly predetermined distance into one of the first or second chambers.

Abstract: Scanning fiber devices are disclosed. In one aspect, a scanning fiber device may include an actuator tube. The scanning fiber device may also include a cantilevered free end portion of an optical fiber. The cantilevered free end portion of the optical fiber may have an attached end that is coupled with the actuator tube. The cantilevered free end portion of the optical fiber may also have a free end to be moved by the actuator tube. At least a portion of a length of the cantilevered free end portion of the optical fiber may be disposed within the actuator tube. Methods of using scanning fiber devices are also disclosed.